Kuda Mutasa1, Robert Ntozini1, Mduduzi N N Mbuya1,2, Sandra Rukobo1, Margaret Govha1, Florence D Majo1, Naume Tavengwa1, Laura E Smith1,3, Laura Caulfield4, Jonathan R Swann5,6, Rebecca J Stoltzfus7, Lawrence H Moulton4, Jean H Humphrey1,4, Ethan K Gough4, Andrew J Prendergast1,8. 1. Zvitambo Institute for Maternal and Child Health Research, Harare, Zimbabwe. 2. Global Alliance for Improved Nutrition, Washington, DC, USA. 3. Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY, USA. 4. Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 5. Division of Digestive Diseases, Department of Metabolism, Digestion, and Reproduction, Faculty of Medicine, Imperial College London, London, United Kingdom. 6. School of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom. 7. Program in International Nutrition, Division of Nutritional Sciences, Cornell University, Ithaca, NY, USA. 8. Blizard Institute, Queen Mary University of London, London, United Kingdom.
Abstract
BACKGROUND: Child stunting remains a poorly understood, prevalent public health problem. Environmental enteric dysfunction (EED) is hypothesized to be an important underlying cause. OBJECTIVES: Within a subgroup of 1169 children enrolled in the SHINE (Sanitation Hygiene Infant Nutrition Efficacy) trial in rural Zimbabwe, followed longitudinally from birth to 18 mo of age, we evaluated associations between the concentration of 11 EED biomarkers and linear growth velocity. METHODS: At infant ages 1, 3, 6, 12, and 18 mo, nurses measured child length and collected stool and blood; the lactulose-mannitol urine test was also conducted at all visits except at 1 mo. Stool neopterin, α-1 antitrypsin, myeloperoxidase, and regenerating gene 1β protein; urinary lactulose and mannitol; and plasma kynurenine, tryptophan, C-reactive protein, insulin-like growth factor-1 (IGF-1), soluble CD14, intestinal fatty acid binding protein, and citrulline were measured. We analyzed the change in relative [∆ length-for-age z score (LAZ)/mo] and absolute (∆ length/mo) growth velocity during 4 age intervals (1-3 mo; 3-6 mo; 6-12 mo; and 12-18 mo) per SD increase in biomarker concentration at the start of each age interval. RESULTS: In fully adjusted models, we observed only 3 small, statistically significant associations: kynurenine:tryptophan ratio at 12 mo was associated with decreased mean LAZ velocity during the 12-18 mo interval (-0.015 LAZ/mo; 95% CI: -0.029, -0.001 LAZ/mo); mannitol excretion at 6 mo was associated with increased LAZ velocity during the 6-12 mo interval (0.013 LAZ/mo; 95% CI: 0.001, 0.025 LAZ/mo), and plasma IGF-1 at 1 mo was associated with increased LAZ velocity during the 1-3 mo interval (0.118 LAZ/mo; 95% CI: 0.024, 0.211 LAZ/mo). Results for absolute growth velocity were similar, except IGF-1 was also associated with growth during the 12-18 mo interval. We found no other associations between any EED biomarker and linear growth velocity. CONCLUSIONS: None of 11 biomarkers of EED were consistently associated with linear growth among Zimbabwean children.This trial was registered at clinicaltrials.gov as NCT01824940.
BACKGROUND:Child stunting remains a poorly understood, prevalent public health problem. Environmental enteric dysfunction (EED) is hypothesized to be an important underlying cause. OBJECTIVES: Within a subgroup of 1169 children enrolled in the SHINE (Sanitation Hygiene Infant Nutrition Efficacy) trial in rural Zimbabwe, followed longitudinally from birth to 18 mo of age, we evaluated associations between the concentration of 11 EED biomarkers and linear growth velocity. METHODS: At infant ages 1, 3, 6, 12, and 18 mo, nurses measured child length and collected stool and blood; the lactulose-mannitol urine test was also conducted at all visits except at 1 mo. Stool neopterin, α-1 antitrypsin, myeloperoxidase, and regenerating gene 1β protein; urinary lactulose and mannitol; and plasma kynurenine, tryptophan, C-reactive protein, insulin-like growth factor-1 (IGF-1), soluble CD14, intestinal fatty acid binding protein, and citrulline were measured. We analyzed the change in relative [∆ length-for-age z score (LAZ)/mo] and absolute (∆ length/mo) growth velocity during 4 age intervals (1-3 mo; 3-6 mo; 6-12 mo; and 12-18 mo) per SD increase in biomarker concentration at the start of each age interval. RESULTS: In fully adjusted models, we observed only 3 small, statistically significant associations: kynurenine:tryptophan ratio at 12 mo was associated with decreased mean LAZ velocity during the 12-18 mo interval (-0.015 LAZ/mo; 95% CI: -0.029, -0.001 LAZ/mo); mannitol excretion at 6 mo was associated with increased LAZ velocity during the 6-12 mo interval (0.013 LAZ/mo; 95% CI: 0.001, 0.025 LAZ/mo), and plasma IGF-1 at 1 mo was associated with increased LAZ velocity during the 1-3 mo interval (0.118 LAZ/mo; 95% CI: 0.024, 0.211 LAZ/mo). Results for absolute growth velocity were similar, except IGF-1 was also associated with growth during the 12-18 mo interval. We found no other associations between any EED biomarker and linear growth velocity. CONCLUSIONS: None of 11 biomarkers of EED were consistently associated with linear growth among Zimbabwean children.This trial was registered at clinicaltrials.gov as NCT01824940.
Authors: Sebastian Vollmer; Kenneth Harttgen; Malavika A Subramanyam; Jocelyn Finlay; Stephan Klasen; S V Subramanian Journal: Lancet Glob Health Date: 2014-03-27 Impact factor: 26.763
Authors: Laura D Howe; Kate Tilling; Bruna Galobardes; George Davey Smith; David Gunnell; Debbie A Lawlor Journal: J Epidemiol Community Health Date: 2010-08-18 Impact factor: 3.710
Authors: O Yaw Addo; Aryeh D Stein; Caroline H Fall; Denise P Gigante; Aravinda M Guntupalli; Bernardo L Horta; Christopher W Kuzawa; Nanette Lee; Shane A Norris; Poornima Prabhakaran; Linda M Richter; Harshpal S Sachdev; Reynaldo Martorell Journal: J Pediatr Date: 2013-03-07 Impact factor: 4.406
Authors: Clair Null; Christine P Stewart; Amy J Pickering; Holly N Dentz; Benjamin F Arnold; Charles D Arnold; Jade Benjamin-Chung; Thomas Clasen; Kathryn G Dewey; Lia C H Fernald; Alan E Hubbard; Patricia Kariger; Audrie Lin; Stephen P Luby; Andrew Mertens; Sammy M Njenga; Geoffrey Nyambane; Pavani K Ram; John M Colford Journal: Lancet Glob Health Date: 2018-01-29 Impact factor: 26.763
Authors: Xueheng Zhao; Kenneth D R Setchell; Rong Huang; Indika Mallawaarachchi; Lubaina Ehsan; Edward Dobrzykowski Iii; Junfang Zhao; Sana Syed; Jennie Z Ma; Najeeha T Iqbal; Junaid Iqbal; Kamran Sadiq; Sheraz Ahmed; Yael Haberman; Lee A Denson; Syed Asad Ali; Sean R Moore Journal: J Nutr Date: 2021-12-03 Impact factor: 4.798
Authors: Jenna N Diaz; Sherlie Jean Louis Dulience; Noah Wolthausen; Xuntian Jiang; Emmanuel Gyimah; Francesca J Marhône Pierre; F Matthew Kuhlmann; Lora L Iannotti Journal: Curr Dev Nutr Date: 2022-09-12